Skip to main content

Table 1 Participant characteristics of 57 nurses and physicians in oncology/haematology

From: Are cancer patients better off if they participate in clinical trials? A mixed methods study

 

Nurse (%) (n = 31)

Physician (%) (n = 26)

Total (%) (n = 57)

Country

 Denmark

19 (61,3)

17 (65,4)

36 (63,1)

 Sweden

12 (38,7)

9 (34,6)

21 (36,9)

Sex

 Female

29 (93,5)

18 (69,2)

47 (82,5)

 Male

2 (6,5)

8 (30,8)

9 (17,5)

Age

 ≤ 30–39

11 (35,8)

8 (30,8)

18 (33,3)

 40–49

10 (32,1)

11 (42,3)

22 (38,6)

 ≤ 50–59

10 (32,1)

7 (26,9)

17 (29,7)

Education

 Bachelor (3 years)

22 (71,0)

22 (38,6)

 Specialist nurses

9 (29,0)

9 (15,7)

 Physicians (≥5 years)

9 (34,6)

9 (15,7)

 PhD

17 (65,4)

17 (29,8)

Years as nurse/physician

 Mean

14,9 (0,3 to 35)

16,4 (1 to

15,5 (0,3 to

 ≤ 10

13 (42,0)

8 (30,7)

21 (36,0)

 > 10

7 (22,5)

9 (34,6)

16 (28,0)

 > 20

11(35,5)

9 (34,6)

20 (36,0)

Years in oncology/ haematology

 Mean

11,2 (0,3 to 35)

7,4 (1 to 40)

9,5 (0,3 to 40)

 ≤ 10

17 (54,8)

13 (50,0)

30 (52,6)

 > 10

8 (25,8)

7 (27,0)

15 (26,3)

 > 20

6 (19,3)

6 (23,0)

12 (21,1)

Clinical trial setting

 Phase I

13 (41,9)

11 (42,3)

24 (42,1)

 Phase II

14 (41,1)

16 (61,5)

30 (52,6)

 Phase III

27 (87,0)

24 (92,3)

51 (89,5)